{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:13:27Z","timestamp":1772165607434,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Res Methodol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Test-negative design (TND) studies are increasingly common in evaluating vaccine effectiveness (VE) for various infectious diseases. TND studies are susceptible to bias due to disease outcome misclassification caused by imperfect test sensitivity and specificity. Several bias correction methods have been proposed. However, sample size or power considerations for TND studies incorporating bias correction for such misclassification have not yet been investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used Monte Carlo simulations to assess how bias correction affects the statistical power and sample size for VE estimation in TND studies. Simulations were conducted under varying levels of diagnostic test sensitivities (60%, 80%, and 95%). Bias correction was implemented using the multiple over-imputation method, which accounts for test misclassification through a parametric bootstrapping approach. Using a malaria vaccine as an example, we defined six vaccination status categories based on the time since receipt of the third or fourth vaccine dose. In the simulated target population, vaccination coverage was assumed to be low (&lt;\u200910%) except for the group vaccinated more than 12 months after dose 4. We assumed relatively low VE (&lt;\u200950%) against clinical malaria cases and a 30% malaria positivity rate among unvaccinated individuals presenting with malaria-related symptoms. Statistical power to detect VE was estimated for each vaccination status, both with and without bias correction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Estimated VEs based on observed data were consistently underestimated across all vaccination status groups due to diagnostic misclassification. In contrast, bias-corrected estimates were approximately unbiased but displayed wider confidence intervals, with their precision decreasing at lower test sensitivities. Statistical power to detect VE declined substantially when diagnostic test sensitivity was low. For instance, at 80% sensitivity, only three vaccination status groups reached 80% power with a sample size of 10,000, whereas the same power was achieved with just 6,000 individuals under a perfect test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Bias due to imperfect diagnostic testing can substantially reduce the power of TND studies. Power calculations should account for outcome misclassification and potential correction methods. Failure to do so may lead to underpowered studies and misleading VE estimates.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12874-025-02628-9","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T13:53:01Z","timestamp":1753797181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Power and sample size considerations for test-negative design with bias correction: a case study on the world first malaria vaccine"],"prefix":"10.1186","volume":"25","author":[{"given":"Yura K.","family":"Ko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Alfv\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Yoneoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"issue":"1","key":"2628_CR1","first-page":"43","volume":"31","author":"H Chua","year":"2020","unstructured":"Chua H, Feng S, Lewnard JA, et al. The use of test-negative controls to monitor vaccine effectiveness: A systematic review of methodology: A systematic review of methodology. Epidemiology Ovid Technol (Wolters Kluwer Health). 2020;31(1):43\u201364.","journal-title":"Epidemiology Ovid Technol (Wolters Kluwer Health)"},{"issue":"37","key":"2628_CR2","first-page":"20585","volume":"18","author":"G De Serres","year":"2013","unstructured":"De Serres G, Skowronski DM, Wu XW, Ambrose CS. The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials. Euro Surveill.\u00a0European Centre for Disease Control and Prevention (ECDC). 2013;18(37):20585.","journal-title":"Euro Surveill.\u00a0European Centre for Disease Control and Prevention (ECDC)"},{"issue":"12","key":"2628_CR3","doi-asserted-by":"publisher","first-page":"e072144","DOI":"10.1136\/bmjopen-2023-072144","volume":"13","author":"O Mweso","year":"2023","unstructured":"Mweso O, Simwanza J, Malambo W, et al. Test negative case-control study of COVID-19 vaccine effectiveness for symptomatic SARS-CoV-2 infection among healthcare workers: zambia, 2021\u20132022. BMJ Open BMJ Open. 2023;13(12):e072144.","journal-title":"BMJ Open BMJ Open"},{"issue":"12","key":"2628_CR4","doi-asserted-by":"publisher","first-page":"e0278546","DOI":"10.1371\/journal.pone.0278546","volume":"17","author":"J Belayachi","year":"2022","unstructured":"Belayachi J, Obtel M, Mhayi A, Razine R, Abouqal R. Long term effectiveness of inactivated vaccine BBIBP-CorV (Vero Cells) against COVID-19 associated severe and critical hospitalization in Morocco. PLoS One Public Libr Sci (PLoS). 2022;17(12):e0278546.","journal-title":"PLoS One Public Libr Sci (PLoS)"},{"key":"2628_CR5","doi-asserted-by":"crossref","unstructured":"Chiwandire N, Walaza S, von Gottberg A et al. Estimation of vaccine effectiveness against SARS-CoV-2-associated hospitalization using sentinel surveillance in South Africa. Int J Epidemiol [Internet]. Oxford University Press (OUP); 2024;53(5). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39305220\/.","DOI":"10.1093\/ije\/dyae116"},{"issue":"10462","key":"2628_CR6","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/S0140-6736(24)01738-0","volume":"404","author":"AB Payne","year":"2024","unstructured":"Payne AB, Watts JA, Mitchell PK, et al. Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis. Lancet Elsevier BV. 2024;404(10462):1547\u201359.","journal-title":"Lancet. Elsevier BV"},{"issue":"11","key":"2628_CR7","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.vaccine.2015.01.069","volume":"33","author":"ML Jackson","year":"2015","unstructured":"Jackson ML, Rothman KJ. Effects of imperfect test sensitivity and specificity on observational studies of influenza vaccine effectiveness. Vaccine. 2015;33(11):1313\u20136.","journal-title":"Vaccine"},{"key":"2628_CR8","first-page":"e216","volume-title":"Epidemiol Infect","author":"A Endo","year":"2020","unstructured":"Endo A, Funk S, Kucharski AJ. Bias correction methods for test-negative designs in the presence of misclassification. In: Epidemiol Infect, vol. 148. Cambridge University Press (CUP); 2020. p. e216."},{"issue":"1","key":"2628_CR9","first-page":"322","volume":"22","author":"J Kabalu Tshiongo","year":"2023","unstructured":"Kabalu Tshiongo J, Luzolo F, Kabena M, et al. Performance of ultra-sensitive malaria rapid diagnostic test to detect plasmodium falciparum infection in pregnant women in kinshasa, the Democratic Republic of the congo. Malar J Springer Sci Bus Media LLC. 2023;22(1):322.","journal-title":"Malar J Springer Sci Bus Media LLC"},{"issue":"1","key":"2628_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12936-023-04506-5","volume":"22","author":"S Opoku Afriyie","year":"2023","unstructured":"Opoku Afriyie S, Addison TK, Gebre Y, et al. Accuracy of diagnosis among clinical malaria patients: comparing microscopy, RDT and a highly sensitive quantitative PCR looking at the implications for submicroscopic infections. Malar J. 2023;22(1):76.","journal-title":"Malar J"},{"issue":"9988","key":"2628_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","volume":"386","author":"RTS,S Clinical Trials Partnership","year":"2015","unstructured":"RTS,S Clinical Trials Partnership. Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in africa: final results of a phase 3, individually randomised, controlled trial. Lancet Lancet. 2015;386(9988):31\u201345.","journal-title":"Lancet Lancet"},{"issue":"10016","key":"2628_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0140-6736(15)00725-4","volume":"387","author":"MA Penny","year":"2016","unstructured":"Penny MA, Verity R, Bever CA, et al. Public health impact and cost-effectiveness of the RTS,S\/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models. Lancet. 2016;387(10016):367\u201375.","journal-title":"Lancet"},{"key":"2628_CR13","doi-asserted-by":"crossref","unstructured":"Ko YK, Kagaya W, Yoneoka D, et al. Where is the hard-to-reach population? Spatial analysis from a cross-sectional study on the access to bed net and malaria vaccine in the Lake Victoria Region, Kenya. Malar J. 2025;24(1):42.","DOI":"10.1186\/s12936-025-05280-2"},{"key":"2628_CR14","doi-asserted-by":"crossref","unstructured":"Ko YK, Kagaya W, Omondi P, et al. Evaluation of the protective efficacy of OlysetPlus ceiling nets for reduction of malaria incidence in children in Homa Bay County, Kenya: a cluster-randomised controlled study protocol. BMJ Open. 2025;15(1):e087832.","DOI":"10.1136\/bmjopen-2024-087832"},{"issue":"1","key":"2628_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12874-024-02277-4","volume":"24","author":"Y Huo","year":"2024","unstructured":"Huo Y, Yang Y, Halloran ME, Longini IM Jr, Dean NE. Hypothesis testing and sample size considerations for the test-negative design. BMC Med Res Methodol Springer Science and Business Media LLC. 2024;24(1):151.","journal-title":"BMC Med Res Methodol. Springer Science and Business Media LLC"},{"issue":"3","key":"2628_CR16","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/ije\/dym021","volume":"36","author":"EW Orenstein","year":"2007","unstructured":"Orenstein EW, De Serres G, Haber MJ, et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol. 2007;36(3):623\u201331.","journal-title":"Int J Epidemiol"},{"issue":"33","key":"2628_CR17","doi-asserted-by":"publisher","first-page":"5071","DOI":"10.1016\/j.vaccine.2018.06.072","volume":"36","author":"M Haber","year":"2018","unstructured":"Haber M, Lopman BA, Tate JE, Shi M, Parashar UD. A comparison of the test-negative and traditional case-control study designs with respect to the bias of estimates of rotavirus vaccine effectiveness. Vaccine. 2018;36(33):5071\u20136.","journal-title":"Vaccine"},{"issue":"1","key":"2628_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12874-023-01962-0","volume":"23","author":"F Habibzadeh","year":"2023","unstructured":"Habibzadeh F. Correction of vaccine effectiveness derived from test-negative case-control studies. BMC Med Res Methodol. 2023;23(1):137.","journal-title":"BMC Med Res Methodol"},{"issue":"5","key":"2628_CR19","first-page":"660","volume":"33","author":"AB Amin","year":"2022","unstructured":"Amin AB, Lash TL, Tate JE, et al. Understanding variation in rotavirus vaccine effectiveness estimates in the united states: the role of rotavirus activity and diagnostic misclassification. Epidemiology Ovid Technol (Wolters Kluwer Health). 2022;33(5):660\u20138.","journal-title":"Epidemiology Ovid Technol (Wolters Kluwer Health)"},{"key":"2628_CR20","first-page":"1633","volume-title":"Children (Basel)","author":"HS Yoon","year":"2022","unstructured":"Yoon HS, Sohn Y-H, Chae JD, Lim J, Kim SY. Characterization of Rotavirus infection in hospitalized children under 5 with acute gastroenteritis 5 years after introducing the Rotavirus vaccines in South Korea. In: Children (Basel), vol. 9. MDPI AG; 2022. p. 1633."},{"key":"2628_CR21","unstructured":"World Health Organization. Evaluation of COVID-19 vaccine effectiveness. 2021. Available from: https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-vaccine_effectiveness-measurement-2021.1. Cited 2025 Jan 20."},{"issue":"6","key":"2628_CR22","doi-asserted-by":"publisher","first-page":"e0199180","DOI":"10.1371\/journal.pone.0199180","volume":"13","author":"T De Smedt","year":"2018","unstructured":"De Smedt T, Merrall E, Macina D, Perez-Vilar S, Andrews N, Bollaerts K. Bias due to differential and non-differential disease- and exposure misclassification in studies of vaccine effectiveness. PLoS ONE. 2018;13(6):e0199180.","journal-title":"PLoS ONE"}],"container-title":["BMC Medical Research Methodology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-025-02628-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12874-025-02628-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-025-02628-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:40:12Z","timestamp":1757313612000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedresmethodol.biomedcentral.com\/articles\/10.1186\/s12874-025-02628-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2628"],"URL":"https:\/\/doi.org\/10.1186\/s12874-025-02628-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.03.12.25323823","asserted-by":"object"}]},"ISSN":["1471-2288"],"issn-type":[{"value":"1471-2288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,29]]},"assertion":[{"value":"25 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"178"}}